Quality of life in Parkinson's disease.

Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease. Neurol Sci (2015) 0.77

Development, reliability and validity of the psychosocial adaptation scale for Parkinson's disease in Chinese population. Int J Clin Exp Med (2015) 0.75

A Kinect-Based Physiotherapy and Assessment Platform for Parkinson's Disease Patients. J Med Eng (2016) 0.75

Health-related quality of life in Parkinson's disease patients in northeastern Sicily, Italy: (An ecological perspective). Neural Regen Res (2013) 0.75

The influence of depression, level of functioning in everyday life, and illness acceptance on quality of life in patients with Parkinson's disease: a preliminary study. Neuropsychiatr Dis Treat (2017) 0.75

Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity. NPJ Parkinsons Dis (2017) 0.75

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02

EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70

A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17

EuroQol: the current state of play. Health Policy (1996) 27.78

The Sickness Impact Profile: development and final revision of a health status measure. Med Care (1981) 18.20

Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med (1998) 13.87

The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res (2004) 9.79

Health status: types of validity and the index of well-being. Health Serv Res (1976) 5.55

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res (1995) 5.36

A method for evaluating disability in patients with Parkinson's disease. J Nerv Ment Dis (1961) 3.14

The Sleep Disorders Questionnaire. I: Creation and multivariate structure of SDQ. Sleep (1994) 3.04

Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) Age Ageing (1995) 2.92

Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 2.23

How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord (2000) 2.23

Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord (2002) 2.21

Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry (1996) 2.17

Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire. Age Ageing (1999) 1.96

Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry (2002) 1.94

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry (2002) 1.90

Parkinson's disease and sleepiness: an integral part of PD. Neurology (2002) 1.85

Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology (2008) 1.80

Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.75

The quality of life in Parkinson's disease. Mov Disord (2000) 1.54

Fatigue in Parkinson's disease. Neurology (1993) 1.46

Assessment of cognition in Parkinson's disease. Neurology (2003) 1.45

Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale. Eur J Neurol (2002) 1.35

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord (2011) 1.31

The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand (2003) 1.29

Sleep attacks and Parkinson's disease treatment. Lancet (2000) 1.25

Anxiety and Parkinson's disease. J Neuropsychiatry Clin Neurosci (1996) 1.24

Fatigue in patients with Parkinson's disease. Mov Disord (1999) 1.21

The Parkinson's Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson's disease. Clin Rehabil (2001) 1.16

Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord (2003) 1.09

Parkinson's disease and anxiety. Postgrad Med J (2001) 1.08

Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurol (1995) 1.08

Evaluating the evaluations: or how to weigh the scales of parkinsonian disability. Neurology (1983) 1.06

Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees. Parkinsonism Relat Disord (2005) 1.05

Anxiety disorders in Parkinson's disease. Adv Neurol (2005) 1.03

Quality of life in stroke patients. Acta Neurol Scand (2003) 1.02

Development and testing of the Parkinson's disease quality of life scale. Mov Disord (2003) 1.01

Quality of life and the anxiety disorders. J Anxiety Disord (2003) 1.01

Quality of life measurements in patients with Parkinson's disease: A community-based study. Eur J Neurol (1998) 0.99

Quality of life in multiple sclerosis. J Med Life (2011) 0.97

Quality of life of post-stroke patients and their caregivers. J Med Life (2010) 0.94

Diurnal effects of motor activity and fatigue in Parkinson's disease. J Neurol Neurosurg Psychiatry (1993) 0.93

Sleep in Parkinson's disease. Acta Neurol Scand (1993) 0.89

The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study. J Neurol (2001) 0.86

Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial. Trials (2009) 0.86

Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study. Mov Disord (2000) 0.83

Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol (2006) 0.83

Parkinson's disease complicated by anxiety. Mayo Clin Proc (1987) 0.83

Dopamine agonists and sleep in Parkinson's disease. Neurology (2002) 0.81

Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS). Parkinsonism Relat Disord (1996) 0.81

[Current possibilities of evaluation of quality of life in Parkinson disease]. Neurol Neurochir Pol (2003) 0.76

Activities of daily living and quality of life in Alzheimer disease. J Med Life (2012) 0.76

1998 world Federation of interventional and therapeutic neuroradiology. Guidelines for fellowship training programmes in interventional neuroradiology. Interv Neuroradiol (2001) 1.53

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology (1999) 1.52

The burden of brain diseases in Europe. Eur J Neurol (2003) 1.51

Applying the International Classification of Functioning, Disability and Health (ICF) to measure childhood disability. Disabil Rehabil (2003) 1.38

Treatment of herniated lumbar disc by intradiscal and intraforaminal oxygen-ozone (O2-O3) injection. J Neuroradiol (2004) 1.29

Epidemiology and genetics of intracranial aneurysms. Eur J Radiol (2013) 1.21

Instrumental monitoring of the birth and development of truffles in a Tuber melanosporum orchard. Mycorrhiza (2014) 1.10

Disability in chronic daily headache: state of the art and future directions. Neurol Sci (2011) 1.06

Complications in the treatment of intracranial aneurysms with silk stents: an analysis of 30 consecutive patients. Interv Neuroradiol (2012) 1.05

Human herpesvirus-7 in Brazilian liver transplant recipients: a follow-up comparison between molecular and immunological assays. Transpl Infect Dis (2009) 0.98

Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol (2009) 0.96

The use of flow-diverting stents in the treatment of giant cerebral aneurysms: preliminary results. Neuroradiol J (2010) 0.96

Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol (2007) 0.94

Recurrent inflammatory myofibroblastic tumor of the glottis mimicking malignancy. Am J Otolaryngol (1997) 0.92

MR/CT image fusion of the spine after spondylodesis: a feasibility study. Eur Spine J (2010) 0.91

Disability and quality of life in headache: where we are now and where we are heading. Neurol Sci (2013) 0.90

A minimally invasive treatment for lumbar disc herniation: DiscoGel® chemonucleolysis in patients unresponsive to chemonucleolysis with oxygen-ozone. Interv Neuroradiol (2012) 0.90

Molecular genetics applied to clinical practice: the Cx26 hearing impairment. Br J Audiol (1999) 0.89

Management of unruptured brain aneurysms: retrospective analysis of a single centre experience. Neuroradiol J (2013) 0.88

Burden of caregivers of patients in Vegetative state and minimally conscious state. Acta Neurol Scand (2012) 0.88

3T MRI in the Evaluation of Brain Aneurysms Treated with Flow-Diverting Stents: Preliminary Experience. Neuroradiol J (2009) 0.88

Functional MRI: primary motor cortex localization in patients with brain tumors. J Comput Assist Tomogr (1996) 0.87

Iopamidol 300-induced epilepsy: intensive treatment and pathogenic hypothesis. Neuroradiology (1988) 0.87

Use of Glubran 2 acrylic glue in interventional neuroradiology. Neuroradiology (2007) 0.86

Role of catheter angiography in diagnostic neuroradiology. AJNR Am J Neuroradiol (1995) 0.86

Qualitative MRI findings in patients with schizophrenia: a controlled study. Psychiatry Res (2000) 0.85

Metabolic abnormalities in pain-processing regions of patients with fibromyalgia: a 3T MR spectroscopy study. AJNR Am J Neuroradiol (2011) 0.85

Assessment of the ecological status of transitional waters in Sicily (Italy): first characterisation and classification according to a multiparametric approach. Mar Pollut Bull (2010) 0.84

Disability and mood state in patients with episodic and chronic migraine associated to medication overuse. Neurol Sci (2012) 0.84

Aroma characterisation and UV elicitation of purple basil from different plant tissue cultures. Food Chem (2013) 0.83

Children in vegetative state and minimally conscious state: patients' condition and caregivers' burden. ScientificWorldJournal (2012) 0.83

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? Neurooncol Pract (2014) 0.82

Physical and mental health, anxiety and depressive symptoms in caregivers of patients in vegetative state and minimally conscious state. Clin Psychol Psychother (2013) 0.82

Caregiving for patients in vegetative and minimally conscious states: perceived burden as a mediator in caregivers' expression of needs and symptoms of depression and anxiety. J Clin Psychol Med Settings (2014) 0.82

WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study. AJNR Am J Neuroradiol (2014) 0.81

Role of neuroradiology in evaluating cerebral aneurysms. Interv Neuroradiol (2008) 0.81

Staged treatment of a blood blister-like aneurysm with stent-assisted coiling followed by flow diverter in-stent insertion. A case report. Interv Neuroradiol (2011) 0.81

Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurol Sci (2015) 0.80

In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS. Int J Oncol (1998) 0.80

[A direct radiological sign of meningioma of the anterior angle of the chiasma: "pneumosinus dilatans" (author's transl)]. Ann Radiol (Paris) (1976) 0.80

Approaches to treatments of chronic migraine associated with medication overuse: a comparison between different intensity regimens. Neurol Sci (2015) 0.80

Presurgical embolization of spinal tumours using glubran 2 acrylic glue. Interv Neuroradiol (2004) 0.79

CT angiography in an acute stroke protocol: correlation between occlusion site and outcome of intravenous thrombolysis. Interv Neuroradiol (2013) 0.79

CT evaluation of the lumbosacral spine. AJNR Am J Neuroradiol (1983) 0.79

Clinical use of prostacyclin (PGI2) in ischaemic stroke. Pharmacol Res Commun (1982) 0.79

Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci (2014) 0.79

[Mixed dentition space analysis in a eastern Sicilian population]. Minerva Stomatol (2002) 0.79

Neurologists and patients' associations: alliances and conflicts. Neurol Sci (2006) 0.79

FMRI activation with an "affective speech" paradigm in vegetative and minimally conscious States: applicability and prognostic value. Neuroradiol J (2012) 0.79

Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms. Oncol Rep (1998) 0.79

Role of contrast-enhanced magnetic resonance angiography in spinal dural arteriovenous fistula. Neuroradiol J (2010) 0.78

Activated T cells in Graves' disease before treatment. Clin Exp Immunol (1985) 0.78

Otorhinolaryngological aspects of HIV infections: personal experience. Allergol Immunopathol (Madr) (1995) 0.78

Importance of functional MRI and the role of stereotactic biopsy in the diagnosis of cerebral lymphoma. Neuroradiol J (2008) 0.78

In vitro and in vivo antifungal activity of some essential oils against feline isolates of Microsporum canis. J Mycol Med (2012) 0.78

[Stereotactic biopsy and brachytherapy in the diagnostics and treatment of brain tumors--preliminary report]. Neurol Neurochir Pol (2001) 0.77

CE-MR Angiography at 3.0 T Magnetic Field in the Study of Spinal Dural Arteriovenous Fistula. Preliminary Results. Interv Neuroradiol (2007) 0.77

Detection and monitoring of human herpesvirus 7 in adult liver transplant patients: impact on clinical course and association with cytomegalovirus. Transplant Proc (2007) 0.77

Do diagnostic differences between vegetative state and minimally conscious state patients correspond to differences in functioning and disability profiles? Results from an observational multi-center study on patients with DOC. Eur J Phys Rehabil Med (2014) 0.77

Association between Developmental Venous Anomalies and Cavernous Angiomas: a Retrospective MR Study. Neuroradiol J (2009) 0.77

Antifungal activity of 2-(4-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, the analog of Ebselen. Arch Immunol Ther Exp (Warsz) (1999) 0.77

Experimental allergic encephalomyelitis in chickens. Arch Immunol Ther Exp (Warsz) (1978) 0.77

Revascularized giant aneurysm of the anterior communicating artery after surgery and embolization, occluded by placement of a Leo+Baby intracranial stent. A case report. Neuroradiol J (2013) 0.77

Selenium status and GSH-Px activity in semen and blood of boars at different ages used for artificial insemination. Reprod Domest Anim (2004) 0.77

Diastematomyelia in an adult. Case report. Ital J Neurol Sci (1983) 0.77

[Earthquake in Abruzzo, public health interventions. Preliminary report]. Ann Ig (2010) 0.77

Seasonal dynamics of prokaryotic abundance and activities in relation to environmental parameters in a transitional aquatic ecosystem (Cape Peloro, Italy). Microb Ecol (2013) 0.76

A study on the occurrence of polyovular follicles in porcine ovaries with particular reference to intrafollicular hormone concentrations, quality of oocytes and their in vitro fertilization. Anat Histol Embryol (2009) 0.76

Semisynthetic human insulin: biologic and immunologic activity in newly treated diabetic subjects during a six-month follow-up. Diabetes Care (1984) 0.76

Activities of daily living and quality of life in Alzheimer disease. J Med Life (2012) 0.76

Intra-arterial Chemotherapy with Carboplatin (CBDCA) and Vepesid (VP16) in Primary Malignant Brain Tumours. Preliminary Findings. Interv Neuroradiol (2001) 0.75

MRI findings in low grade tumours associated with focal cortical dysplasia. Neuroradiol J (2012) 0.75

Complications of carotid angioplasty and stenting. AJNR Am J Neuroradiol (2012) 0.75

Contrast medium dose and renal failure. Radiology (1998) 0.75

[Pulling ears]. Radiol Med (1999) 0.75

Myelography with axial tomography and a new contrast medium: iopamidol (B 15,000). J Neuroradiol (1981) 0.75

fMRI changes in the brain associated with the carotid compression test. J Comput Assist Tomogr (1998) 0.75

[Gaucher's disease: description of a clinical case and review of the literature]. G Clin Med (1988) 0.75

Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography. Acta Radiol Suppl (1986) 0.75

The economic cost of the medical-legal tort system. Am J Obstet Gynecol (1996) 0.75

Cellulosic membranes and leukocytes are not effective for in vitro generation of beta 2-microglobulin. Nephrol Dial Transplant (1988) 0.75

Aztreonam uptake by professional phagocytic cells. Chemioterapia (1987) 0.75

Haematopoietic factors in haemodialysed patients. Epidemiologic study and therapeutic suggestions. Haematologica (1987) 0.75

[Study of the muscles by computerized tomography in neuromuscular diseases]. Minerva Pediatr (1986) 0.75

[Ultrasonographic study in the evaluation of acute capsulo-ligamentous lesions of the medial compartment of the knee]. Chir Organi Mov (1988) 0.75

An ischaemic thalamic lesion extending to the mammillothalamic tract associated with absent ipsilateral mammillary body in a patient with temporal lobe epilepsy. A case report. Neuroradiol J (2009) 0.75

[Experimental research on the use of fluorocarbon compounds (FC 43) as blood substitutes]. Boll Soc Ital Biol Sper (1981) 0.75

Presentation. Interv Neuroradiol (2001) 0.75

Adverse Reactions to Iodinated Contrast Media: Prevention, Diagnosis and Treatment. Le reazioni avverse da mezzi di contrasto iodati prevenzione, diagnosi e terapia. Neuroradiol J (2009) 0.75

[Stereotactic convergence irradiation with linear accelerator. Imaging,technique and clinical indications]. Rontgenpraxis (1998) 0.75

Editorial. Neuroradiol J (2009) 0.75

Why should neuroradiology be a specialty? The Italian situation. J Neuroradiol (2000) 0.75

Ruptured "occult" aneurysm disclosed by three-dimensional angiographic reconstructions. Neuroradiol J (2009) 0.75

Potential of high field functional MRI in the neuroradiological diagnosis of brain tumours. Neuroradiol J (2009) 0.75

A meeting of vascular neurosurgeons and therapeutic neuroradiologists. "Who treats what?" June 1995--"Fondation les Treilles" (France). J Neurosurg Sci (1998) 0.75

[Contribution to our knowledge about complicated migraine. Clinical and instrumental study]. Riv Neurobiol (1983) 0.75

A new method for the quantitative determination of osteoporosis in man. Ital J Orthop Traumatol (1978) 0.75

Acid-base balance during biofiltration (BF). Int J Artif Organs (1986) 0.75

Three-dimensional computerised tomography of the orbit. J Neuroradiol (1978) 0.75

The revision of the International Classification of Impairments, Disabilities and Handicaps and its application in MS. Mult Scler (1999) 0.75